Literature DB >> 31018795

Ischemic stroke: clinical pathway impact.

Antonio Giulio de Belvis1,2, Franziska Michaela Lohmeyer3, Andrea Barbara3, Gabriele Giubbini3, Carmen Angioletti1, Giovanni Frisullo2,4, Walter Ricciardi3,5,6, Maria Lucia Specchia3.   

Abstract

PURPOSE: A clinical pathway for patients with acute ischemic stroke was implemented in 2014 by one Italian teaching hospital multidisciplinary team. The purpose of this paper is to determine whether this clinical pathway had a positive effect on patient management by comparing performance data. DESIGN/METHODOLOGY/APPROACH: Volume, process and outcome indicators were analyzed in a pre-post retrospective observational study. Patients' (admitted in 2013 and 2015) medical records with International Classification of Diseases, ICD-9 code 433.x (precerebral artery occlusion and stenosis), 434.x (cerebral artery occlusion) and 435.x (transient cerebral ischemia) and registered correctly according to hospital guidelines were included.
FINDINGS: An increase context-sensitive in-patient numbers with more severe cerebrovascular events and an increase in patient transfers from the Stroke to Neurology Unit within three days (70 percent, p=0.25) were noted. Clinical pathway implementation led to an increase in patient flow from the Emergency Department to dedicated specialized wards such as the Stroke and Neurology Unit (23.7 percent, p<0.001). Results revealed no statistically significant decrease in readmission rates within 30 days (5.7 percent, p=0.85) and no statistically significant differences in 30-day mortality. RESEARCH LIMITATIONS/IMPLICATIONS: The pre-post retrospective observational study design was considered suitable to evaluate likely changes in patient flow after clinical pathway implementation, even though this design comes with limitations, describing only associations between exposure and outcome. ORIGINALITY/VALUE: Clinical pathway implementation showed an overall positive effect on patient management and service efficiency owing to the standardized application in time-dependent protocols and multidisciplinary/integrated care implementation, which improved all phases in acute ischemic stroke care.

Entities:  

Keywords:  Appropriateness; Clinical governance; Clinical pathway; Stroke

Year:  2019        PMID: 31018795     DOI: 10.1108/IJHCQA-05-2018-0111

Source DB:  PubMed          Journal:  Int J Health Care Qual Assur        ISSN: 0952-6862


  5 in total

1.  Effect of lockdown on the management of ischemic stroke: an Italian experience from a COVID hospital.

Authors:  Giovanni Frisullo; Valerio Brunetti; Riccardo Di Iorio; Aldobrando Broccolini; Pietro Caliandro; Mauro Monforte; Roberta Morosetti; Carla Piano; Fabio Pilato; Paolo Calabresi; Giacomo Della Marca
Journal:  Neurol Sci       Date:  2020-07-06       Impact factor: 3.307

2.  Stroke integrated care pathway during COVID-19 pandemic.

Authors:  Giovanni Frisullo; Antonio Giulio De Belvis; Giacomo Della Marca; Carmen Angioletti; Paolo Calabresi
Journal:  Neurol Sci       Date:  2020-06-03       Impact factor: 3.307

3.  Construction of Clinical Pathway Information Management System under the Guidance of Evidence-Based Medicine.

Authors:  Xinyu Wang; Jie Chen; Fang Peng; Jingtai Lu
Journal:  J Healthc Eng       Date:  2021-12-02       Impact factor: 2.682

4.  Patient Pathways During Acute in-Hospital Stroke Treatment: A Qualitative Multi-Method Study.

Authors:  Loraine Busetto; Johanna Hoffmann; Christina Stang; Hemasse Amiri; Fatih Seker; Jan Purrucker; Peter Arthur Ringleb; Simon Nagel; Martin Bendszus; Wolfgang Wick; Christoph Gumbinger
Journal:  Int J Integr Care       Date:  2022-02-21       Impact factor: 5.120

5.  Definition and conceptualization of the patient-centered care pathway, a proposed integrative framework for consensus: a Concept analysis and systematic review.

Authors:  Jean-Baptiste Gartner; Kassim Said Abasse; Frédéric Bergeron; Paolo Landa; Célia Lemaire; André Côté
Journal:  BMC Health Serv Res       Date:  2022-04-26       Impact factor: 2.908

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.